Compare TLS & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLS | CLPT |
|---|---|---|
| Founded | 1969 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.1M | 353.5M |
| IPO Year | 2020 | 2009 |
| Metric | TLS | CLPT |
|---|---|---|
| Price | $4.68 | $11.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $7.90 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 583.9K | 497.4K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.51 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $164,805,000.00 | $36,971,000.00 |
| Revenue This Year | $18.72 | $45.67 |
| Revenue Next Year | $14.62 | $19.51 |
| P/E Ratio | $155.00 | ★ N/A |
| Revenue Growth | ★ 52.21 | 17.78 |
| 52 Week Low | $2.37 | $8.27 |
| 52 Week High | $8.36 | $30.10 |
| Indicator | TLS | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 58.46 | 51.09 |
| Support Level | $3.88 | $10.09 |
| Resistance Level | $4.65 | $11.73 |
| Average True Range (ATR) | 0.28 | 0.96 |
| MACD | 0.04 | -0.11 |
| Stochastic Oscillator | 72.29 | 28.17 |
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.